Curative treatment for stage IIIC2 cervical cancer: what to expect?
Geovanne Pedro MauroVinicius de Aquino CalheirosMatheus Sorgi VonsowskiTalita AvelarHeloisa de Andrade CarvalhoPublished in: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology (2023)
Patients with current stage IIIC2 cervix cancer may present long term survival. Treating positive PAN cervical cancer patients with concurrent chemoradiation including brachytherapy with curative intent should be standard. Poor PS and more advanced pelvic disease may represent a higher risk for worse outcomes. Distant metastases are still a challenge for disease control.